SCHEMBL22705366

SCHEMBL22705366

CCCCc1cc(O)c(C2C=C(C)CCC2)c(OC(C)C)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 5/20 0.50
ACE2 Q9BYF1 2/20 0.50
CNR2 P34972 11/20 0.48
CNR1 P21554 8/20 0.45
TRPV1 Q8NER1 2/20 0.45
NR1I2 O75469 2/20 0.45
LDHA P00338 2/20 0.45
TRPM8 Q7Z2W7 2/20 0.45
GPR55 Q9Y2T6 2/20 0.45
MLNR O43193 1/20 0.45
PDE9A O76083 1/20 0.45
ABCB11 O95342 1/20 0.45
CYP1A1 P04798 1/20 0.45
CYP1A2 P05177 1/20 0.45
CHRM2 P08172 1/20 0.45
CYP3A4 P08684 1/20 0.45
HTR1A P08908 1/20 0.45
ADORA3 P0DMS8 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2A6 P11509 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31545843 0.97 OPRM1 (0.54) OPRM1ACE2CNR2CNR1TRPV1
SCHEMBL23099242 0.97 OPRM1 (0.54) OPRM1ACE2CNR2CNR1TRPV1
SCHEMBL22705572 0.96 OPRM1 (0.53) OPRM1ACE2CNR2CNR1TRPV1
SCHEMBL22705425 0.96 OPRM1 (0.53) OPRM1ACE2CNR2CNR1TRPV1
SCHEMBL22705545 0.96 OPRM1 (0.53) OPRM1ACE2CNR2CNR1TRPV1
SCHEMBL22705592 0.96 OPRM1 (0.53) OPRM1ACE2CNR2CNR1TRPV1
SCHEMBL22705431 0.96 OPRM1 (0.53) OPRM1ACE2CNR2CNR1TRPV1
SCHEMBL31545405 0.93 CNR2 (0.46) OPRM1ACE2CNR2CNR1TRPV1
SCHEMBL23155072 0.93 CNR2 (0.46) OPRM1ACE2CNR2CNR1TRPV1
SCHEMBL18391714 0.93 CNR2 (0.46) OPRM1ACE2CNR2CNR1TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250090554-A1 A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION MYND LIFE SCIENCES INC (CA) 2025-03-20 US disclosed
WO-2021163023-A1 STABLE FORMULATIONS OF DRONABINOL TRYAGx Labs Inc. (US) 2021-08-19 WO disclosed
WO-2020232545-A1 CATALYTIC CANNABINOID PROCESSES AND PRECURSORS KARE CHEMICAL TECHNOLOGIES INC. (CA) 2020-11-26 WO disclosed